Wednesday 29 November 2017 by William Arnold Company updates

Capitol Health announces takeover of Integral Diagnostics

Capitol Health has announced a takeover of Integral Diagnostics Ltd

Capitol Health (Capitol) has announced a takeover of Integral Diagnostics Ltd (ASX: IDX). Bridging finance has been approved and Capitol has re-confirmed its intention to refinance all debt post completion (including the 8.25% May 2020 bond).

Main points:

  • Capitol Health has announced an off market takeover offer for Integral Diagnostics
  • The offer equates to a total $52.2m of cash and  6.9 shares in Capitol for each Integral share
  • Capitol has already accumulated 19.55% in pre bid acceptance agreements from a number of institutional IDX holders
  • MergeCo is estimated to have underlying pro forma FY18 EBITDA of $64m; pro forma FY18 net debt of $70m (1.09x leverage) that is conservative which supports its refinance position
  • New funding arrangements in place consisting of a bridging facility of $100m, supplementing Capitol’s existing $35m. Capitol’s unsecured notes will remain in place and following completion of the transaction “Capitol intends to refinance MergeCo’s debt”

The ASX release can be found here.

Get your free copy of The Benefits of Corporate Bonds eBook

Get a copy of The Benefits of Corporate Bonds eBook

Warren Hogan Webinar - Can the economic miracle continue?

Subscribe to The WIRE newsletter

Sign up to a free weekly newsletter to get the latest investment news.